Direct-to-Consumer Laboratory Testing Market (Sample Type: Blood, Urine, Saliva, and Others; Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Diabetes Testing, TSH Testing, and Others; and End User: Hospitals, Clinics, Specialty Labs, and Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2030

The global direct to consumer laboratory testing market is projected to advance at a CAGR of 26.2% during 2022–2030. User convenience and promising outcomes are key propositions for the demand for DTC laboratory testing. Furthermore, the confidentiality of the consumer is propelling the popularity of DTC lab testing for various types such as genetic testing, disease risk assessment testing, CBC, diabetes testing, TSH testing.

Individuals are becoming more involved in decisions pertaining to their wellbeing and are seeking provisions that enable them increased control over their personal health information. Notable benefits include patient's autonomy, self-empowerment, and timely access to molecular and immunological tests for infectious and chronic diseases.

Both growing skills of laboratory technicians and promising regulatory frameworks have advanced the scope of results obtained from DTC testing. Consumers are increasingly seeking new technologies in the direct-to-consumer laboratory testing market for application in monitoring existing health conditions and gaining access to personal health characteristics for wellness.

Growing Consumer Preference to Perform Tests with Confidentiality Boosts Market Growth

The DTC testing is an interesting extension to the traditional healthcare model for customers desiring information of their health situation and disease risk, ancestry, and their body's expected response to certain prescriptions based on their genotype. The advantages of DTC testing are enticing and driving the direct-to-consumer laboratory testing market. The traditional model of laboratory testing in healthcare begins with the patient identifying the need to see a doctor. Waiting for test results and interpretative data from their doctor can be a source of stress. Reasonably, consumers are ready for a new healthcare model with increased convenience and detailed diagnostic reports without having to go through lengthy procedures. Moreover, the direct-to-consumer laboratory testing menu is ever-expanding, and DTC tests are promoted for a variety of uses. Typical sample types are cheek swabs, saliva or spit, urine, hair, blood spots, or blood. Moreover, there are thousands of DTC tests presently available with more being developed. One common test is DTC genetic tests, which use a saliva sample and is analyzed by genotyping.

The difficulty of scheduling and waiting for an appointment with physician conflicts with consumers' lifestyles. In-office wait times can be long and are negatively associated with patient satisfaction and the likelihood to recommend a physician. On the contrary, DTC companies allow testing without an appointment. Many businesses also offer telehealth benefits for consumers to discuss lab results with a medical professional. Additionally, another appeal of DTC lab tests is confidentiality. Results cannot be shared with anyone unless patients share the result themselves. People may feel more comfortable attempting out testing options for sexually transmitted infections, screening for drugs of abuse, reproduction, and fertility-related tests when the results will be confidential. All these factors are most likely to fuel the demand for the global direct-to-consumer laboratory testing market during the projected timeline.

Direct-to-Consumer Laboratory Testing Market: Key Segments

In terms of sample type, the global direct-to-consumer laboratory testing market has been classified into blood, urine, saliva, and others. The saliva segment is projected to account for a major share of the market. The segment’s dominance can be attributed to increase in the number of DTC testing companies offering saliva-based test kits.

Based on test type, the global direct-to-consumer laboratory testing market has been categorized into genetic testing, disease risk assessment testing, CBC, diabetes testing, TSH testing, and others. The disease risk assessment testing segment has been further split into cancer, STDs, and others. The genetic testing segment dominated the market in 2021. Number of users of DTC test kits for ancestry and health & fitness has increased at a rapid pace. The number of people interested in knowing about their ancestors and family tree has increased, which is also anticipated to increase the demand for DNA test kits, especially in developed countries across the globe.

In terms of end user, the global direct-to-consumer laboratory testing market has been classified into hospitals, clinics, specialty labs, and diagnostic centers. The diagnostic centers segment is projected to account for a major share of the market. Rise in the number of public–private partnerships is expected to drive the segment during the forecast period.

Market size and forecast for each of these segments have been provided from 2017 to 2030. The CAGR of respective segments has also been provided from 2022 to 2030, considering 2020 as the base year.

North America to Lead Direct-to-Consumer Laboratory Testing Market

The rising prevalence of lifestyle-associated and contagious diseases in North America is likely to drive the direct-to-consumer laboratory testing market during the forecast period. Furthermore, increasing consumer awareness and enhancing lifestyles in Europe are expected to boost the direct-to-consumer laboratory testing market in the region.  In addition, the increase in government initiatives to promote enhanced, user-friendly diagnostics and genetic research in countries across Asia is expected to fuel the growth of the direct-to-consumer laboratory testing market.

Some of the prominent players in the Direct-to-Consumer Laboratory Testing Market include:

  • Color Genomics
  • LetsGetChecked
  • WellnessFX
  • MyMedLab, Inc.
  • LLC
  • DirectLabs, LLC
  • EverlyWell, Inc.
  • 23andMe, Inc.
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:

Direct-to-Consumer Laboratory Testing Market, by Sample Type

  • Blood
  • Urine
  • Saliva
  • Others

Direct-to-Consumer Laboratory Testing Market, by Test Type

  • Genetic Testing
  • Disease Risk Assessment Testing
    • Cancer
    • STDs
    • Others
  • CBC
  • Diabetes Testing
  • TSH Testing
  • Others

Direct-to-Consumer Laboratory Testing Market, by End User

  • Hospitals
  • Clinics
  • Specialty Labs
  • Diagnostic Centers

By Geography

North America

  • U.S.
  • Canada


  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Key Points Covered in Direct-to-Consumer Laboratory Testing Market Study:

  • Growth of Direct-to-Consumer Laboratory Testing in 2022
  • Market Estimates and Forecasts (2017-2030)
  •  Brand Share and Market Share Analysis
  •  Key Drivers and Restraints Shaping Market Growth
  •  Segment-wise, Country-wise, and Region-wise Analysis
  •  Competition Mapping and Benchmarking
  •  Recommendation on Key Winning Strategies
  •  COVID-19 Impact on Demand for Direct-to-Consumer Laboratory Testing and How to Navigate
  •  Key Product Innovations and Regulatory Climate
  •  Direct-to-Consumer Laboratory Testing Consumption Analysis
  •  Direct-to-Consumer Laboratory Testing Production Analysis
  •  Direct-to-Consumer Laboratory Testing and Management